Tesoro assay results provide positive share price momentum

|

Published 06-APR-2020 11:57 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Shares in Tesoro Resources Limited (ASX:TSO) traded more than 10% higher on Monday morning after the company released surface assay results for rock chip samples and soil samples from the Espina Gold Project, Chile.

The results further enhance Espina’s potential to host large scale, high grade gold mineralisation.

Espina is Tesoro’s second Chilean project and is located about 50 kilometres from the Chilean capital city, Santiago.

In late 2019, prior to the company’s admission to the ASX, a detailed mapping and sampling program was undertaken at Espina to assess previously identified gold mineralisation along the Puertelera and Infernillio Structures.

A total of 130 rock chip, channel samples and 441 soil samples were collected from this area which is illustrated below.

Results have delineated zones of strong gold mineralisation along the Puertelera structure and a large gold in soil anomaly at the northern end of the Infernillio Structure at Dona Clara which lies to the west of Libera.

Gold rich portion appears to be preserved

Associated geochemical anomalism also indicates that the gold rich zone of the Espina epithermal system remains preserved and has not been eroded away, further enhancing the prospectivity of the project.

Commenting on these recent developments and their impact on the group’s exploration strategy, Tesoro managing director Zeff Reeves said, “The surface results from Espina reinforce our view that the project is highly prospective, as they not only demonstrate the extensive strike of the mineralised structures, but more importantly the geochemical signature tells us that the gold rich portion of the system appears to be preserved and has not been eroded away.

‘’This further enhances the project and we will continue to focus on the resultant stronger zones of the system to delineate drill targets.”

Tesoro plans to continue exploration at Espina with the aim of delineating future drill targets.

Next steps will include trenching across prospective mineralised zones along the Puertelera trend and at Dona Clara (see below) to obtain controlled bedrock samples and provide detailed geological information.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X